Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C3AR1 | Q16581 | 1/20 | 0.39 |
| ▸ | GGT1 | P19440 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.31 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.30 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.30 |
| ▸ | NPY4R | P50391 | 3/20 | 0.30 |
| ▸ | NPY1R | P25929 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14848974 | 0.86 | C3AR1 (0.34) | C3AR1MEN1GAAKMT2AITGB3 | |
| SCHEMBL1344935 | 0.83 | C3AR1 (0.38) | C3AR1GGT1MEN1GAAKMT2A | |
| SCHEMBL144726 | 0.82 | GGT1 (0.40) | C3AR1GGT1MEN1GAAKMT2A | |
| SCHEMBL20016348 | 0.82 | NPY4R (0.32) | C3AR1MEN1GAAKMT2AITGB3 | |
| SCHEMBL18806927 | 0.81 | C3AR1 (0.36) | C3AR1MEN1GAAKMT2AITGB3 | |
| SCHEMBL1149706 | 0.81 | NOD1 (0.43) | C3AR1GGT1MEN1GAAKMT2A | |
| SCHEMBL20016340 | 0.81 | ALOX15 (0.32) | MEN1KMT2AALOX15 | |
| SCHEMBL611883 | 0.80 | GGT1 (0.53) | C3AR1GGT1MEN1GAAKMT2A | |
| SCHEMBL1007743 | 0.80 | GGT1 (0.53) | C3AR1GGT1MEN1GAAKMT2A | |
| SCHEMBL13060031 | 0.80 | GGT1 (0.38) | C3AR1GGT1MEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9994464-B2 | Method and devices for de-emulsifying and complexing organic compounds in emulsions | DREI LILIEN PVG GMBH & CO. KG (DE) | 2018-06-12 | — | — | US | disclosed |
| US-9932540-B2 | Method for refining lipid phases, and use | DREI LILIEN PVG GMBH & CO. KG (DE) | 2018-04-03 | — | — | US | disclosed |
| US-20170260072-A1 | METHOD AND DEVICES FOR DE-EMULSIFYING AND COMPLEXING ORGANIC COMPOUNDS IN EMULSIONS | DREI LILIEN PVG GMBH & CO. KG (DE) | 2017-09-14 | — | — | US | disclosed |
| US-20170135363-A1 | METHOD FOR REFINING LIPID PHASES, AND USE | DREI LILIEN PVG GMBH & CO. KG (DE) | 2017-05-18 | — | — | US | disclosed |
| US-20170121360-A1 | APPARATUS AND METHOD FOR OBTAINING GLYCOGLYCEROLIPIDS AND GLYCOSPHINGOLIPIDS FROM LIPID PHASES | GEA WESTFALIA SEPARATOR GROUP GMBH (DE) | 2017-05-04 | — | — | US | disclosed |
| US-20160122686-A1 | DEVICE AND METHOD FOR SOLUBILIZING, SEPARATING, REMOVING AND REACTING CARBOXYLIC ACIDS IN OILS, FATS, AQUEOUS OR ORGANIC SOLUTIONS BY MEANS OF MICRO-OR NANOEMULSIFICATION | DIETZ ULRICH (DE) | 2016-05-05 | — | — | US | disclosed |
| US-9127233-B2 | Device and method for solubilizing, separating, removing and reacting carboxylic acids in oils, fats, aqueous or organic solutions by means of micro-or nanoemulsification | Dietz, Ulrich (DE) | 2015-09-08 | — | — | US | disclosed |
| US-20130090488-A1 | DEVICE AND METHOD FOR SOLUBILIZING, SEPARATING, REMOVING AND REACTING CARBOXYLIC ACIDS IN OILS, FATS, AQUEOUS OR ORGANIC SOLUTIONS BY MEANS OF MICRO-OR NANOEMULSIFICATION | DIETZ ULRICH (DE) | 2013-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170121360-A1 | APPARATUS AND METHOD FOR OBTAINING GLYCOGLYCEROLIPIDS AND GLYCOSPHINGOLIPIDS FROM LIPID PHASES | AGL, LIPA, MGLL | C3AR1 1202/4885GGT1 132/4885MEN1 3664/4885 |
| US-20170260072-A1 | METHOD AND DEVICES FOR DE-EMULSIFYING AND COMPLEXING ORGANIC COMPOUNDS IN EMULSIONS | LIPA, AP2S1, DEGS1 | C3AR1 1484/4885GGT1 1584/4885MEN1 4759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.